NYSE:DGX

Quest Diagnostics Stock News

Healthcare > Medical - Diagnostics & Research

Buy DGX

*Your capital is at risk

$233.72

+1.77 (+0.763%)

At Close: Aug 04, 2026

Quest Diagnostics (DGX) Volume Growth Aids, Margin Woes Stay

05:53pm, Tuesday, 06'th Dec 2022 Zacks Investment Research

Quest Diagnostics' (DGX) legacy base business is growing amid softer utilization trends.

Quest Diagnostics (DGX) Volume Growth Aids, Margin Woes Stay

02:18pm, Tuesday, 06'th Dec 2022

Quest Diagnostics' (DGX) legacy base business is growing amid softer utilization trends.

Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus

11:58am, Monday, 28'th Nov 2022 Zacks Investment Research

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022

03:13pm, Thursday, 17'th Nov 2022 Benzinga

Upgrades Wolfe Research upgraded the previous rating for Matson Inc (NYSE:MATX) from Underperform to Peer Perform. In the third quarter, Matson showed an EPS of $6.89, compared to $6.53 from the year-

Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday

12:35pm, Thursday, 17'th Nov 2022 Benzinga

Citigroup cut Quest Diagnostics Incorporated (NYSE: DGX) price target from $145 to $125. . Citigroup analyst Patrick Donnelly downgraded the stock from Neutral to Sell. Quest Diagnostics shares rose

Where Quest Diagnostics Stands With Analysts

12:03pm, Thursday, 17'th Nov 2022 Benzinga

Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 3 0 1

Beat the Market Like Zacks: JPMorgan, Berkshire Hathaway, Amgen in Focus

11:55am, Monday, 14'th Nov 2022 Zacks Investment Research

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Quest Diagnostics Is a Wreck Amidst Covid-19 Testing Declines

01:02pm, Monday, 31'st Oct 2022

One of the companies that benefitted hugely from the Covid-19 pandemic was diagnostic testing company Quest Diagnostics Inc ( DGX , Financial), which operates a national network of full-service clinic

Here’s Why Quest Diagnostics Stock Should Be In Your Portfolio

08:58am, Monday, 31'st Oct 2022 Investing.com

Here's Why Quest Diagnostics Stock Should Be in Your Portfolio

01:07am, Monday, 31'st Oct 2022

Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.

COVID-19 testing volume has 'come down,' Quest Diagnostics CEO says

01:39pm, Monday, 24'th Oct 2022

Quest Diagnostics CEO Steve Rusckowski joins Yahoo Finance Live to discuss the state of the coronavirus pandemic, testing demand, manufacturing capacity, and the outlook for the industry.